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Abstract
Background: Hyperglycaemia occurs frequently in critically ill patients without diabetes. We conducted a systematic
review and meta-analysis to evaluate whether this ‘stress hyperglycaemia’ identifies survivors of critical illness at
increased risk of subsequently developing diabetes.
Methods: We searched the MEDLINE and Embase databases from their inception to February 2016. We included
observational studies evaluating adults admitted to the intensive care unit (ICU) who developed stress hyperglycaemia
if the researchers reported incident diabetes or prediabetes diagnosed ≥3 months after hospital discharge. Two
reviewers independently screened the titles and abstracts of identified studies and evaluated the full text of
relevant studies. Data were extracted using pre-defined data fields, and risk of bias was assessed using the
Newcastle-Ottawa Scale. Pooled ORs with 95 % CIs for the occurrence of diabetes were calculated using a
random-effects model.
Results: Four cohort studies provided 2923 participants, including 698 with stress hyperglycaemia and 131 cases
of newly diagnosed diabetes. Stress hyperglycaemia was associated with increased risk of incident diabetes (OR 3.48;
95 % CI 2.02–5.98; I2 = 36.5 %). Studies differed with regard to definitions of stress hyperglycaemia, follow-up and
cohorts studied.
Conclusions: Stress hyperglycaemia during ICU admission is associated with increased risk of incident diabetes.
The strength of this association remains uncertain because of statistical and clinical heterogeneity among the
included studies.
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Background
‘Stress hyperglycaemia’ is defined as a blood glucose
concentration that, in health, would lead to a diagnosis
of diabetes [1–3] and represents a state of temporary
insulin resistance and concomitant relative insulin defi-
ciency [4, 5]. While stress hyperglycaemia is associated with
greater illness severity and short-term mortality [2, 6, 7], it
typically resolves, at least acutely, following recovery [8].
For this reason, stress hyperglycaemia has traditionally not
been considered to have an adverse impact on long-term
health. It is plausible, however, that critical illness un-
covers latent insulin resistance and/or impaired pancreatic
β-cell function, such that stress hyperglycaemia identifies
patients at risk of subsequently developing diabetes [9].
Transient hyperglycaemia occurring in other contexts
of physiological ‘stress’, such as pregnancy, is known to
predict the development of diabetes [10–12]. Post-partum
screening programmes for women with gestational dia-
betes allow early identification of type 2 diabetes to delay
or reduce the associated complications [13–15].
The impact of stress hyperglycaemia on the risk of
incident diabetes for survivors of critical illness remains
unclear. We therefore performed a systematic review
and meta-analysis of observational studies to evaluate
the longitudinal risk of developing diabetes in critically
ill patients with stress hyperglycaemia. Our secondary
objective was to evaluate the impact of stress hypergly-
caemia on the risk of prediabetes (impaired fasting glucose
and/or impaired glucose tolerance).
Methods
We performed this meta-analysis in accordance with the
Meta-analysis of Observational Studies in Epidemiology
(MOOSE) statement [16]. Methods and inclusion criteria
were specified and documented in advance (Additional
file 1).
Eligibility criteria
Eligible studies met the following criteria: (a) retro-
spective or prospective controlled study design (case-
control or controlled cohort), (b) study population of
adult patients (aged ≥18 years) admitted to an intensive
care unit (ICU), (c) exposure to stress hyperglycaemia
with normoglycaemia during ICU admission as the ref-
erence exposure and (d) outcomes of development of
diabetes or prediabetes diagnosed ≥3 months after ICU
discharge. Studies that reported a diagnosis of diabetes
only at ICU admission or shortly after ICU discharge
(within 3 months) were excluded, as they were deemed
to be reporting rates of established but previously undiag-
nosed diabetes [2]. Studies that reported outcomes for
acutely ill patients not admitted to an ICU were excluded.
In studies with overlapping samples, we included only the
largest study to avoid duplication of data. We considered
only studies reported in English. No date or publication
status restrictions were imposed.
Data sources and searches
A librarian and two reviewers (YA and PK) searched the
MEDLINE and Embase databases (from their inception
to February 2016). Searches included synonyms and
combinations of the following terms: ‘critical illness’,
‘intensive care’, ‘hyperglycaemia’, ‘glucose’, ‘insulin’, ‘type 2
diabetes’ and ‘prediabetes’. Terms were truncated in
order to capture variable terminology. The full search
strategies are provided in Additional file 2. We applied
no language restrictions during the searches. We also
reviewed reference lists of retrieved papers to identify
other potentially eligible studies not captured in the
primary search.
Study selection
Two reviewers independently screened titles and abstracts
of all identified studies. Relevant studies were independ-
ently evaluated in full text for eligibility. Disagreements
were resolved by consensus or by consultation with a third
reviewer. In order to avoid duplications from several re-
ports of the same study, a comparison was conducted
across studies when needed, checking for authors, study
locations, sample sizes and outcomes.
Quality assessment
Two reviewers independently assessed methodological
quality using the 8-item Newcastle-Ottawa Scale (NOS)
[17]. Risk of bias was assigned on the basis of the number
of NOS items deemed inadequate for each study: low risk
of bias (0 or 1 item), medium risk of bias (two or three
items), high risk of bias (more than three items) or very
high risk of bias (no description of methods). Studies
judged to be at high or very high risk of bias were ex-
cluded from the meta-analysis.
Data extraction
Two reviewers independently extracted data from included
studies using a standardized data collection form. Extracted
information included study characteristics (author, publi-
cation year, country, design, sample size), participant char-
acteristics (age, sex, diagnosis, illness severity, mortality,
body mass index [BMI], family history of diabetes, steroid
use, nutrition delivery), definition of stress hyperglycaemia
and method of detection, methods to exclude pre-existing
undiagnosed diabetes, definitions of diabetes and predia-
betes, methods to diagnose diabetes or prediabetes, dur-
ation of follow-up, ORs for the development of diabetes
and/or prediabetes with corresponding 95 % CIs, and
any statistical adjustment performed for the competing
risk of death.
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The supplementary files of all included studies were
also examined for the purposes of data extraction. When
necessary, we contacted the authors of the included
studies for additional information.
Data synthesis and statistical analysis
The OR (95 % CI) was used as the measure of associ-
ation between stress hyperglycaemia and the develop-
ment of diabetes or prediabetes across the studies. We
used the Cochran Q statistic (p < 0.1) and the I2 statistic
to investigate the possibility of statistical heterogeneity
[18]. Meta-analysis was performed using a random-effects
model, and a pooled OR with 95 % CI was calculated. We
elected a priori to perform an additional subgroup analysis
of studies that excluded patients with pre-existing unrec-
ognised diabetes on the basis of glycated haemoglobin
(HbA1c) level on ICU admission [19]. As there were only
a small number of studies, graphic representation of
publication bias was not performed [20]. Analyses were
performed using STATA version 14.1 software (StataCorp,
College Station, TX, USA).
Results
Study selection
Our search yielded 2389 non-duplicate citations. We dis-
carded 2331 (on the basis of title and abstract) because
they did not meet the inclusion criteria. Five additional
records were identified from reference lists of relevant
retrieved articles, with 63 articles evaluated in full text.
Of these, 18 were not controlled studies, 23 did not as-
sess a relevant outcome, 12 were not conducted in an ICU
setting, two were duplicate reports, two were not in Eng-
lish and one did not include data on inpatient blood glu-
cose levels. One conference abstract was excluded because
it reported solely patients after coronary artery bypass
graft surgery, and it was not deemed representative of
the majority of patients admitted to the ICU due to the
elective nature of the surgery and its association with a
short ICU stay. After these exclusions, four cohort
studies remained and were included in the analysis
(Fig. 1). Because of the overlapping duration of recruit-
ment periods for two studies at one centre [21, 22], the
primary author was contacted and confirmed that each
cohort contained different study participants.
Fig. 1 Flow diagram for selection of studies, ICU Intensive care unit
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Study characteristics and risk of bias within studies
The characteristics of the included studies [21–24] are
summarised in Table 1. In three single-centre studies,
researchers recalled patients after ICU discharge to test
for diabetes or prediabetes with an oral glucose tolerance
test (OGTT) [21, 22, 24]. Additionally, in one study, re-
searchers performed HbA1c testing at ICU admission and
8 months after discharge, but this was not performed for
all enrolled patients [24]. One study was a multi-centre
database record linkage study evaluating the risk of dia-
betes in patients with stress hyperglycaemia who had
emergency admissions to hospital [23]. Only the subgroup
of patients admitted to the ICU in this study was included.
In total, 2923 ICU survivors from four studies were in-
cluded. Illness severity was inconsistently reported. Only
one study reported ventilation rates and provided illness
severity scores [24]. Three studies defined stress hypergly-
caemia as ≥7.8 mmol/L. The database linkage study used
a higher threshold (≥11.1 mmol/L) [23]. The relationship
between the timing of blood glucose measurement and
the delivery of nutrition was not reported in any study.
Three studies [21, 22, 24] defined diabetes and prediabetes
according to published consensus criteria for plasma
glucose and HbA1c [19]. The database linkage study
[23] determined incident diabetes following registration
with the national register.
The risk of bias within included studies is presented
(Table 2). Three studies [21, 22, 24] were deemed to be
at risk of incomplete outcome data due to the number
and limited description of patients lost to follow-up.
One study provided no description of whether missing
outcome data were equal across the stress hyperglycaemia
and normoglycaemia cohorts [24]. In general, stress hyper-
glycaemia and normoglycaemia cohorts were comparable
in terms of age, sex and, when reported, nutrient delivery.
However, when reported, the stress hyperglycaemia co-
horts had a higher BMI, more frequent family history of
diabetes and greater illness severity. No data on the spe-
cific characteristics of the subgroup of patients admitted
to ICU in the database linkage study [23] were provided.
Finally, each study employed different methods to identify
patients with pre-existing undiagnosed diabetes (Table 1).
No study was deemed at overall high or very high risk
of bias, and therefore all four studies were included in
the meta-analysis.
Stress hyperglycaemia and the risk of diabetes
Among the 2923 participants, 698 (23.9 %) experienced
stress hyperglycaemia and 131 (4.5 %) cases of incident
diabetes were detected during follow-up. Stress hyper-
glycaemia was associated with an increased risk of de-
veloping diabetes in survivors of critical illness, with
low to moderate degrees of heterogeneity between
studies (Fig. 2a).
No studies measured HbA1c levels on ICU admission
for the majority of patients, so we were unable to perform
our pre-specified subgroup analysis. We were unable to
undertake further subgroup analyses to examine the effects
of age, sex and diagnosis because of the small number of
events and inconsistent reporting of this information.
Stress hyperglycaemia and the risk of prediabetes
Three studies [21, 22, 24] reported risk of developing
prediabetes, defined according to the same criteria [19].
Among the 2923 participants, 221 (7.6 %) cases of predi-
abetes were detected during follow-up. Stress hypergly-
caemia was associated with increased risk of developing
prediabetes in survivors of critical illness, with a moder-
ate degree of heterogeneity between studies (Fig. 2b).
Discussion
Main findings
We undertook the first meta-analysis to examine the
impact of stress hyperglycaemia in survivors of critical
illness. Our findings suggest that stress hyperglycaemia
identifies patients at increased risk of incident diabetes.
In addition, stress hyperglycaemia also identified patients
at increased risk of developing prediabetes, a well-accepted
risk factor for type 2 diabetes with an annual conversion
rate in ambulatory subjects of 5–10 % [25]. Our obser-
vations are consistent with outcomes of other studies
performed in non-ICU settings including patients fol-
lowing stroke [26], myocardial infarction [27, 28] and
pneumonia [29] where comparable rates of incident
diabetes following stress hyperglycaemia were observed.
Clinical implications
Our findings have substantial clinical significance. There
usually exists a protracted period of time between the
development of diabetes and its diagnosis, with micro-
vascular complications often established at the time of
diagnosis [30]. If stress hyperglycaemia during critical
illness identifies a population at risk of diabetes, an op-
portunity exists for early diagnosis and intervention to
prevent long-term complications of diabetes. Readily
available and cost-effective strategies, such as the use of
metformin and lifestyle interventions including weight
loss and exercise, exist to reduce progression to diabetes
in at-risk populations. These strategies have been demon-
strated to be effective in patients with prediabetes and in
women with prior gestational diabetes [15, 31–33].
While general population screening programmes for
type 2 diabetes are not always cost-effective [34], targeted
screening of high-risk groups, as is the case in gestational
diabetes, improves health outcomes [35]. Our meta-
analysis suggests that the risk of diabetes in ICU survivors
with stress hyperglycaemia is similar to the risk in women
with gestational diabetes over comparable observation
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periods [10, 12]. Furthermore, survivors of critical illness
often experience long-term physical problems [36–38]
and therefore may have a unique capacity to benefit from
screening programmes to identify prediabetes or diabetes.
Potential mechanisms
Failure of pancreatic β-cells to meet insulin secretory
demand in the face of diminished insulin sensitivity is
fundamental to the pathogenesis of type 2 diabetes [39].
Several mechanisms appear to underlie stress hypergly-
caemia during critical illness, including increased release
of counter-regulatory hormones, altered insulin receptor
signalling due to inflammation, pancreatic β-cell inhibition
and interventions such as administration of glucocorti-
coids or parenteral nutrition [1, 8, 40]. However, the stud-
ies included in our meta-analysis also reported that, in
Fig. 2 a Forest plot showing the risk of diabetes in critically ill adult patients with stress hyperglycaemia. b Forest plot showing the risk of prediabetes
in critically ill adult patients with stress hyperglycaemia. SH stress hyperglycaemia. Prediabetes was defined according to American Diabetes Association
criteria: fasting plasma glucose 5.6–6.9 mmol/L (impaired fasting glucose), or 2-h plasma glucose during 75-g oral glucose tolerance test 7.8–11.0 mmol/L
(impaired glucose tolerance), or glycated haemoglobin 5.7–6.4 % (39–46 mmol/mol) [19]
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patients with stress hyperglycaemia, there was more often
a family history of diabetes and higher BMI, suggesting
that well-accepted risk factors for diabetes also contribute
to the development of stress hyperglycaemia. Mechanistic-
ally, it is highly plausible that one or more pre-existing
disorders of insulin sensitivity and/or production result in
predisposition to stress hyperglycaemia during critical
illness and may lead to subsequent development of dia-
betes. We also speculate that additional mechanisms
may be implicated in the progression to diabetes in sur-
vivors of critical illness. These include the reduction in
physical activity post-ICU [37] and autonomic dysfunc-
tion, which affects more than half of ICU patients [41].
Strengths and limitations
Strengths of our meta-analysis include the structured
search, complete retrieval of the identified research and
validated methods in accordance with the MOOSE state-
ment. Included cohort studies were of reasonable methodo-
logical quality, particularly given the logistical challenges
involved in studying these cohorts, and almost 3000 pa-
tients were included.
However, our study has limitations. We included only
studies in English. We were also unable to exclude publi-
cation bias, and negative studies may be missing, poten-
tially resulting in overestimation of the effect size. Our
meta-analysis reflects data derived from only four studies,
which limits our certainty in the results [42]. In addition,
along with moderate statistical heterogeneity, we observed
considerable clinical heterogeneity between the studies;
for example, definitions of stress hyperglycaemia, methods
of outcome assessment and duration of follow-up differed.
Conceptually, stress hyperglycaemia is defined by a glu-
cose concentration normally indicative of diabetes (i.e.,
random blood glucose ≥11.1 mmol/L). However, a strict
definition has not been consistently applied, and whether a
single elevated reading is sufficient or documentation of
more than one episode of hyperglycaemia is required has
yet to be established. Given that there were no correspond-
ing data identifying that blood glucose concentrations
were fasting or post-prandial, three studies [21, 22, 24]
used a relatively low threshold for stress hyperglycaemia
(≥7.8 mmol/L), which could underestimate the risk of
diabetes. Conversely, the study which utilised a thresh-
old of ≥11.1 mmol/L [23] required only a single elevated
reading, which may not be sufficiently specific to identify
risk, because transient disturbances in blood glucose can
occur during critical illness following administration of
catecholamines or corticosteroids. Furthermore, only two
studies specifically excluded patients who received corti-
costeroids [21, 22].
Overall, the small number of incident events (diabetes)
in our meta-analysis means that our point estimates have
greater uncertainty [43] and that our ability to assess the
effects of age, sex and diagnosis on risk of diabetes is
limited. In addition, some patients with undiagnosed
diabetes may not have been recognised at baseline and
could have been misclassified as incident diabetes cases.
These patients would have been more likely categorised
in the stress hyperglycaemia group, and this differential
misclassification could bias toward inflating the estimates
of risk for incident diabetes. Only one study formally
tested all patients with an OGTT to exclude pre-existing
diabetes [21]. However, gastric emptying is delayed during
critical illness [44], and gastric emptying is a major deter-
minant of oral glucose tolerance in health and diabetes
[44, 45]. This has implications for the interpretation of the
OGTT, such that identification of unrecognised diabetes
using the OGTT in critically ill patients is uncertain. None
of the studies measured HbA1c on admission for the
majority of patients. HbA1c is a validated tool for the
diagnosis of previously unrecognised diabetes in hospita-
lised and critically ill patients [46–48], and consensus
guidelines now recommend the measurement of HbA1c
in all hospitalised patients with hyperglycaemia [49].
Individual study results were also likely influenced by
management of missing data. Most studies had high rates
of withdrawal, and limited descriptions were provided of
patients lost to follow-up. It is plausible that patients lost
to follow-up were those who experienced greater illness
severity and subsequent impaired mobility. These patients
may have a higher risk of disturbed glucose metabolism,
and the true incidence of diabetes may have been underes-
timated. It is also possible that patients who develop
hyperglycaemia during ICU admission are likely to receive
more intense screening for diabetes after hospital discharge
than those who remained normoglycaemic throughout
their ICU admission [49]. Furthermore, in one study,
the duration of follow-up was short (8 months), and
the risk of incident diabetes may increase with period
of observation [24]. Across the four studies included in
our meta-analysis, the OR for incident diabetes was ob-
served to increase with increasing duration of follow-
up. Only one study performed statistical adjustment for
the competing risk of death [23].
There are also limitations on the generalisability of
individual study results, for the following reasons: infor-
mation about illness severity is absent in most studies,
only a small subset of patients was admitted to the ICU
in the large multi-centre study [23], two single-centre
studies [21, 22] included a high proportion of patients
presenting with myocardial ischaemia, and one study
reported high rates of parenteral nutrition administra-
tion [21]. We restricted our search to studies of patients
admitted to the ICU, and our results may not reflect
outcomes of acutely ill patients not admitted to the
ICU. Furthermore, the two studies that demonstrated
the strongest relationship between stress hyperglycaemia
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and subsequent incident diabetes [21, 22] were conducted
in the same centre, and this is a limitation of our findings.
However, it is important to note that these studies had the
longest duration of follow-up and were the only studies to
recall patients regularly after ICU discharge and formally
test for diabetes.
Implications for research
Our meta-analysis supports the concept that stress hyper-
glycaemia is a risk factor for incident diabetes in survivors
of critical illness. A multi-centre, prospective cohort study
with a follow-up period of several years would be required
to precisely quantify this risk. Such a study should define
stress hyperglycaemia on the basis of repeated blood glu-
cose measurements and in relation to nutrient delivery, as
well as utilise routine measurement of HbA1c to exclude
undiagnosed diabetes at baseline. Furthermore, studies
which evaluate mechanisms underlying progressive glu-
cose intolerance are required because such understanding
is critical to guiding intervention.
Conclusions
Stress hyperglycaemia during ICU admission is associated
with increased risk for incident diabetes. The strength of
this relationship should be interpreted with caution be-
cause of statistical and clinical heterogeneity among the
included studies.
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